We just received data on a new analyst forecast for $BDX. William Blair gave a rating of 'Market Perform' for $BDX.
$BDX Analyst Ratings
Wall Street analysts have issued reports on $BDX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 04/23/2025
- UBS issued a "Buy" rating on 12/18/2024
To track analyst ratings and price targets for $BDX, check out Quiver Quantitative's $BDX forecast page.
$BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 03/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BDX Insider Trading Activity
$BDX insiders have traded $BDX stock on the open market 14 times in the past 6 months. Of those trades, 1 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- ROLAND GOETTE (EVP and President, EMEA) has made 0 purchases and 2 sales selling 5,121 shares for an estimated $1,130,528.
- MICHAEL DAVID GARRISON (EVP & President, Medical) has made 0 purchases and 3 sales selling 3,914 shares for an estimated $869,504.
- SHANA CAROL NEAL (EVP and Chief People Officer) has made 0 purchases and 3 sales selling 2,575 shares for an estimated $594,550.
- RICHARD BYRD (EVP & President Interventional) has made 0 purchases and 2 sales selling 2,399 shares for an estimated $541,895.
- DAVID SHAN (EVP and Chief ISC Officer) has made 0 purchases and 2 sales selling 2,000 shares for an estimated $450,375.
- JEFFREY WILLIAM HENDERSON purchased 1,500 shares for an estimated $350,430
- BERTRAM L SCOTT sold 700 shares for an estimated $159,593
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Hedge Fund Activity
We have seen 696 institutional investors add shares of $BDX stock to their portfolio, and 768 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 3,219,317 shares (+36.1%) to their portfolio in Q4 2024, for an estimated $730,366,447
- KOVITZ INVESTMENT GROUP PARTNERS, LLC added 2,722,829 shares (+392.4%) to their portfolio in Q4 2024, for an estimated $617,728,215
- CITADEL ADVISORS LLC added 1,398,984 shares (+376.2%) to their portfolio in Q4 2024, for an estimated $317,387,500
- BANK OF NEW YORK MELLON CORP removed 1,388,519 shares (-42.6%) from their portfolio in Q1 2025, for an estimated $318,054,162
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,251,742 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $283,982,707
- BANK OF AMERICA CORP /DE/ added 1,098,633 shares (+77.8%) to their portfolio in Q4 2024, for an estimated $249,246,868
- NEUBERGER BERMAN GROUP LLC removed 1,071,696 shares (-76.1%) from their portfolio in Q4 2024, for an estimated $243,135,671
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
